Trial Profile
Clinical Trials Insight: 700036319
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 16 Aug 2008
Price :
$35
*
At a glance
- Drugs Interferon beta-1a (Primary) ; Glatiramer acetate; Interferon beta-1b
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Sponsors Biogen Idec
- 16 Aug 2008 New trial record.